Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 4/20 | 0.35 |
| ▸ | MAOA | P21397 | 4/20 | 0.35 |
| ▸ | MAOB | P27338 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13960894 | 1.00 | KDM1A (0.35) | KDM1AMAOAMAOBCYP3A4TDP1 | |
| SCHEMBL25947647 | 0.72 | KDM1A (0.53) | KDM1AMAOAMAOB | |
| SCHEMBL4647455 | 0.71 | — | — | |
| SCHEMBL10906538 | 0.65 | TRPA1 (0.34) | CYP3A4TDP1DRD1 | |
| SCHEMBL15657621 | 0.64 | SLC6A2 (0.31) | — | |
| SCHEMBL12337335 | 0.64 | CYP3A4 (0.41) | KDM1AMAOAMAOBCYP3A4TDP1 | |
| SCHEMBL13447808 | 0.63 | TRPA1 (0.32) | CYP3A4TDP1 | |
| SCHEMBL7523506 | 0.63 | CYP3A4 (0.39) | CYP3A4TDP1 | |
| SCHEMBL3680204 | 0.63 | CYP3A4 (0.39) | CYP3A4TDP1 | |
| SCHEMBL7522233 | 0.63 | CYP3A4 (0.39) | CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100152448-A1 | LIGANDS OF THE BENZO [H] QUINOLINE CLASS AND TRANSITION METAL COMPLEXES CONTAINING THEM AND USE OF SAID COMPLEXES AS CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE (IT) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152448-A1 | LIGANDS OF THE BENZO [H] QUINOLINE CLASS AND TRANSITION METAL COMPLEXES CONTAINING THEM AND USE OF SAID COMPLEXES AS CATALYSTS | ADH5, KCNQ4, KCNQ5 | KDM1A 1764/4885MAOA 350/4885MAOB 191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.